Estimating Number of COVID Vaccine Deaths in America - Updated October 8, 2021
Updated October 8, 2021
By Steve Kirsch, Jessica Rose, Mathew Crawford
Analysis of the Vaccine Adverse Event Reporting System (VAERS) database can be used to estimate the number of excess deaths caused by the COVID vaccines. A simple analysis shows that it is likely that over 150,000 Americans have been killed by the current COVID vaccines as of August 8, 2021.
Winning the War Against Therapeutic Nihilism & Trusted Treatments vs Untested Novel Therapies
Interview with Dr. Ryan Cole About Ivermectin and Covid-19
Safety and efficacy of a MEURI Program for the use of high dose ivermectin in COVID-19 patients
Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
A nosocomial outbreak of SARS-CoV-2 Delta variant infected 42 patients, staff and family members; 39 were fully vaccinated. The attack rate was 10.6% (16/151) among exposed staff and reached 23.7% (23/97) among exposed patients in a highly vaccinated population, 16–26 weeks after vaccination (median: 25 weeks). All cases were linked and traced to one patient. Several transmissions occurred between individuals wearing face masks. Fourteen of 23 patients became severely sick or died, raising a question about possible waning immunity.
Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
September 28, 2021
Slides - Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
Covid-19 Lockdown Cost/Benefits: A Critical Assessment of the Literature
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
We found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions, including masking and testing, should be considered for all in settings with elevated COVID-19 transmission.